[PDF][PDF] Management of Chronic Graft vs Host Disease: The contribution of Cellular Therapies
SMBM Lopes - 2022 - repositorio-aberto.up.pt
… The complete study was published as “Should we use extracorporeal photopheresis more
… Although the long follow-up time of patients allowed us to obtain a considerable amount of …
… Although the long follow-up time of patients allowed us to obtain a considerable amount of …
Le bortezomib après l'allogreffe diminue l'incidence et la sévérité de la maladie du greffon contre l'hôte chronique chez les patients avec un myélome multiple
JS Claveau - 2023 - papyrus.bib.umontreal.ca
… In this retrospective study, we compared the outcome of 46 myeloma patients who received
… de répéter une 2e fois le marqueur positif pour confirmer la maladie progressive. Rechute …
… de répéter une 2e fois le marqueur positif pour confirmer la maladie progressive. Rechute …
[PDF][PDF] Az ultraibolya sugárzás szerepe a kísérletes és klinikai dermatológiában
N Gyöngyösi - 2020 - repo.lib.semmelweis.hu
… It is not only used in phototherapy, but it is also suitable for diagnosing photodermatoses,
studying the photosensitizing effects of various drugs, or studying the efficacy of sunscreens. In …
studying the photosensitizing effects of various drugs, or studying the efficacy of sunscreens. In …